Who invested in Genomics

3 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$93Mraised across 3 rounds since 2014, from 3 sources

$16MVenture$33MRound$45MSeries C

Latest round: Series C, $45MJan 2024
Step-upi: 1.4×
Investors: 10

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20162018202020222024

$16MVenture$33MRound$45MSeries C

First round: Venture, $16M
Biggest round: $45M
Usual gap between rounds: 5.3 years

The rounds

Jan 2024
Series C$45M3 new
Source recorded
Aug 2018
Round$33M4 new1 returning
- IP Group
- Invesco Perpetual
- Vertex
- Oxford Sciences
- Woodford
Reported by Telegraph
Nov 2014
Venture$16M3 new
From a historical funding record

Founders and team

From Genomics's own website: 14 on the team.

David ThorntonPresident
Alex EavisChief Product and Technology Officer
Catherine YongChief of Staff
Dr. Seamus HarrisonChief Medical Officer
Dr. Vincent PlagnolChief Scientific Officer
Sneha BakshiChief People & Operations Officer
Michaela BroadhurstHead of Corporate Development
Alex PasteurBoard Member
Dr Jim TananbaumDirector
Dr Jose-Carlos Gutiérrez-RamosBoard Member
Dr Sam WilliamsDirector
Kristin HerreraIndependent Non-Executive Director
Professor Dame Sally DaviesIndependent Non-Executive Director
Simon DingemansChairman of the Board

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2014Round2018Series C2024

Oxford Science EnterprisesVertex

Woodford Investment Management

Lansdowne PartnersOxford SciencesWoodford

Everyone who backed them

Invesco PerpetualGrowth equity2rounds

IP GroupVC firm1round

Foresite CapitalPrivate equity1round

Oryx FundVC firm1round

Oxford Science EnterprisesVC firm1round

VertexHedge fund1round

Woodford Investment ManagementPrivate equity1round

Lansdowne PartnersVC firm1round

Oxford SciencesGrowth equity1round

Woodfordno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Genomics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.